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Assessment of immediate production impact following attenuated PRRS
type 2 virus vaccination in swine breeding herds
Abstract
Background
To mitigate production impact of porcine reproductive and respiratory syndrome (PRRS) virus outbreaks, it
has been common to preventively vaccinate swine breeding herds using PRRS modified live virus (MLV)
vaccine. However, attenuated PRRS virus (PRRSv) may result negative impact on farm productivity. The
objective of this study was to measure the immediate impact of PRRS type 2 MLV vaccine on breeding herd
performance under field conditions. Eight PRRS-stable farms routinely mass vaccinating females with
commercial PRRS MLV vaccines were enrolled on study. Vaccination dates were collected and weekly
changes in abortions, neonatal losses, pre-weaning mortality, pigs weaned per sow, and wean-to-first-service
interval were assessed for up to 6 weeks after each vaccination. A 6-week period prior to each vaccination was
established as baseline. Statistical process control (SPC) analysis was conducted to detect significant
productivity decreases after MLV interventions, on each farm, and a mixed regression model was used, at the
aggregated data level, to assess the productivity change 6 weeks after PRRS MLV vaccinations, compared to
baseline.
Results
Out of 65 herd-MLV vaccinations, SPC analysis detected increase on abortions 4 times (6.1%), on neonatal
losses 7 times (10.7%), on pre-weaning mortality 2 times (3%), on wean-to-first-service interval 2 times (3%),
and no change in total pigs weaned. On aggregated data analysis, there was no significant change in abortion
rate, neonatal losses, number of pigs weaned per sow, and wean-to-first-service interval. However, there was an
increase of 0.26% of pre-weaning mortality 2 weeks after vaccination compared to the baseline.
Conclusions
Under study conditions, individual PRRS-stable sow farms had experienced transient, and numerically small
changes in productivity following PRRS type 2 MLV vaccination. There was a small increase of pre-weaning
mortality 2 weeks after vaccination, but no evidence of significant production impact at aggregated data
analysis for abortion rate, neonatal losses, pigs weaned per sow and wean-to-first-service interval.
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Abstract
Background: To mitigate production impact of porcine reproductive and respiratory syndrome (PRRS) virus
outbreaks, it has been common to preventively vaccinate swine breeding herds using PRRS modified live virus
(MLV) vaccine. However, attenuated PRRS virus (PRRSv) may result negative impact on farm productivity. The
objective of this study was to measure the immediate impact of PRRS type 2 MLV vaccine on breeding herd
performance under field conditions. Eight PRRS-stable farms routinely mass vaccinating females with commercial
PRRS MLV vaccines were enrolled on study. Vaccination dates were collected and weekly changes in abortions,
neonatal losses, pre-weaning mortality, pigs weaned per sow, and wean-to-first-service interval were assessed for
up to 6 weeks after each vaccination. A 6-week period prior to each vaccination was established as baseline.
Statistical process control (SPC) analysis was conducted to detect significant productivity decreases after MLV
interventions, on each farm, and a mixed regression model was used, at the aggregated data level, to assess the
productivity change 6 weeks after PRRS MLV vaccinations, compared to baseline.
Results: Out of 65 herd-MLV vaccinations, SPC analysis detected increase on abortions 4 times (6.1%), on neonatal
losses 7 times (10.7%), on pre-weaning mortality 2 times (3%), on wean-to-first-service interval 2 times (3%), and no
change in total pigs weaned. On aggregated data analysis, there was no significant change in abortion rate,
neonatal losses, number of pigs weaned per sow, and wean-to-first-service interval. However, there was an increase
of 0.26% of pre-weaning mortality 2 weeks after vaccination compared to the baseline.
Conclusions: Under study conditions, individual PRRS-stable sow farms had experienced transient, and numerically
small changes in productivity following PRRS type 2 MLV vaccination. There was a small increase of pre-weaning
mortality 2 weeks after vaccination, but no evidence of significant production impact at aggregated data analysis
for abortion rate, neonatal losses, pigs weaned per sow and wean-to-first-service interval.
Keywords: Swine, PRRS, Vaccination, MLV, Outbreak, Epidemiology
Background
Porcine reproductive and respiratory syndrome virus
(PRRSv) continues to significantly increase the cost of pig
production due to reproduction losses and reduced
growth performance [1–3]. To reduce losses due to PRRSv
infection, veterinarians have implemented practices to
prevent virus introduction (i.e. biosecurity), as well as
developed strategies to control, and/or eliminate the virus
from individual pig herds and from regions [4–6]. Most
PRRSv control/elimination efforts consist of decreasing
(or eliminating) virus replication in the herd based on a
combination of strategic PRRSv immunization and
changes in pig flow targeting reduction in within-herd
virus transmission [7]. Immunization of US swine popula-
tions against PRRSv has been accomplished in large part
with the use of modified-live (attenuated) virus vaccine
(MLV) or field virus inoculation (FVI) [8].
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The American Association of Swine Veterinarians (AASV)
proposed a standardized terminology for communicating the
PRRS status of breeding herds [9]. Briefly, upon infection
herds are classified as “positive unstable”. When there is the
failure of PRRSv RNA detection by RT-PCR in due-to-wean
piglets for at least 90 consecutive days, the herd is classified
as ‘positive stable’. Then, when there is no evidence of PRRSv
circulation in the breeding herd, as demonstrated by lack of
PRRS-associated clinical signs, and incoming gilts remaining
serologically negative for PRRSv, the herd is defined as
“provisional negative”. Finally, when there is no virus circula-
tion, and no anti-PRRSv antibody circulation in the popula-
tion, the herd is defined as PRRS-negative (or naïve).
Field studies have compared exposure programs to con-
trol PRRSv in sow herds, in terms of time to produce
PRRSv-negative piglets at weaning, and/or production
losses following the outbreak [10, 11]. One important re-
ported finding was that herds with recent history of PRRSv
exposure achieved stability (i.e. failure to detect PRRSv
RNA in due to wean piglets consistently for 3 consecutive
months testing 30 piglets by RT-PCR), and recovered prod-
uctivity significantly sooner than herds without recent his-
tory of PRRSv infection. Another study approached the
question of the economic benefit of practicing preventive
vaccination using attenuated virus vaccine as an attempt to
“build” anti-PRRSv immunity prior to outbreak with wild
type strains [12]. It was demonstrated that in the one hand
vaccination increases herd immunity and reduces
time-to-stability and impact on productivity when the herd
becomes infected with wild type viruses. On the other
hand, preventively vaccinating a breeding herd also in-
creases production costs (vaccine costs) and potentially at-
tenuated PRRSv from vaccines has a negative impact on
farm productivity [13–15]. The study documented that it
was economically beneficial to preventively vaccinate
breeding herds whenever the expected outbreak frequency
was less than every 2.1 years. However, the “2.1 year” mark
is highly sensitive to the attributed “negative impact” of
MLV on PRRS-negative or PRRS-stable breeding herds.
The authors of that study, due to the scarce availability to
studies documenting safety of contemporary attenuated
PRRSv vaccines, used a conservative approach assuming
that preventive use of PRRS MLV vaccines resulted in de-
crease of 1 piglet per sow per year in the breeding herd
productivity. Thus, there is the need to better define the
production impact on PRRS-stable breeding herds adopting
PRRS MLV vaccination.
The objective of this epidemiological study was to meas-
ure the immediate impact of PRRS type 2 MLV on key
breeding herd performance parameters using a natural ex-
periment under field conditions. This information will pro-
vide information to best feed the existing economic models
to assist swine veterinarians to take informed decisions re-
garding the use of PRRS MLV vaccine as a preventive tool.
Methods
Study design
This was a retrospective epidemiological study to evalu-
ate the immediate impact of PRRS MLV vaccination on
the breeding herd productivity. Eight sow farms from a
production system in the USA, classified as PRRS-stable
according to the American Association of Swine Veteri-
narians classification [9], that adopted routinely vaccina-
tions using commercially available PRRS type 2 MLV
vaccines were conveniently identified, and enrolled in
the study. Study herds adopted a whole-herd vaccination
program, where all breeding stock (sows and gilts) in the
farm were exposed to one intramuscular dose (recom-
mended by the fabricant) of MLV regardless of age, par-
ity, or stage of production (lactating, gestating, weaned).
Statistical models were used to assess changes in pro-
duction parameters on six weeks following PRRS MLV
vaccination events, compared to 6 weeks before the in-
terventions (Fig. 1). It was conducted two types of ana-
lysis: a) a herd-level analysis, where statistical process
control (SPC) was implemented on each parameter per
herd, and b) an aggregated analysis, which combined in-
formation from all herds. The period of 6 weeks follow-
ing vaccination was chosen to represent the expected
duration of the viremic phase following infection of indi-
vidual sows pre-exposed to PRRSV. This study was
based on retrospective data, and hence no animal care
and use approval was required.
Production parameters, and vaccination dates
The following production parameters were recorded from
the study herds, in a Microsoft Excel spreadsheet: number
of abortions, defined as the counts of sows that aborted at
least one fetus; pre-weaning mortality, defined as the
number of piglets that were born alive, and died before
weaning; neonatal losses, defined as the difference of aver-
age number of pigs born per litter and number of pigs
born alive per litter; total pigs weaned, defined as the total
number of pigs weaned; and wean-to-first-service interval,
defined as the average number of days between weaning
and first service. All parameters were recorded on a
weekly interval during the study period. The vaccination
dates for each study herd were also collected on a Micro-
soft Excel spreadsheet.
Herd enrollment, eligibility and exclusion criteria
Breeding sow farms were eligible for this study if they were
a) diagnostic evidence to support the status of ‘PRRS stable’
according to the AASV guidelines, b) implementing routine
vaccinations with a commercial PRRS MLV vaccine (PRRS
Ingelvac MLV (Boehringer Ingelheim Vetmedica Inc., St
Joseph, MO); PRRS Ingelvac ATP (Boehringer Ingelheim
Vetmedica Inc., St Joseph, MO); or Fostera PRRS (Zoetis
Inc., Parsippany-Troy Hills, NJ)), c) able to provide
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vaccination dates, and weekly production records required
for this study, and d) not having clinical outbreaks of infec-
tious diseases that may impact the parameters that were
measured, including porcine epidemic diarrhea (PED).
Statistical analysis
A PROC MACONTROL procedure of SAS 9.4 (SAS In-
stitute, Inc., Cary, NC) was used to perform a descriptive
analysis, based on statistical process control (SPC), of
the data on the individual farm level to detect negative
impact on productivity up to 6 weeks after each MLV
intervention, compared to a baseline period of 21 weeks
before the first vaccination of the herd. The exponential
weighted moving average (EWMA) was chosen as a SPC
method and set with 3 sigma (which adjusts the width of
the upper and lower control limits [16]), and a 0.4
lambda constant (which represents the weight assigned
to the most recent sample mean included [16]). A de-
crease in productivity, after up to six weeks following
each MLV intervention, with performance parameters
crossing the EWMA control limits, was defined as a sig-
nal. More specifically, an increase of abortion rate (per-
centage of sows in the herd inventory reported with
abortion event), pre-weaning mortality (percentage of
dead piglets from total pigs born), neonatal losses (dif-
ference of total number of piglets born and piglets born
alive), or wean to first service interval; or a decrease in
total pigs weaned. The frequency of significant changes
in productivity following MLV vaccination, as well as the
magnitude and duration of these changes were reported.
Moreover, it was conducted analysis with the aggregated
data from all herd-vaccinations to assess the ‘production
system effect’ of MLV vaccination on sow farm productiv-
ity. The PROC GLIMMIX procedure of SAS 9.4 (SAS Insti-
tute, Inc., Cary, NC) was used to build a mixed regression
model to assess change of each production parameter up to
6 weeks following the reported PRRS MLV vaccination
date, compared to a 6-week period immediately before vac-
cination. Poisson distribution was used for abortions,
pre-weaning mortality and number of pigs weaned per
week, since those responses were defined as counts. A
log-link function was used in the Poisson models, and an
offset variable was used to adjust the analysis for herd size,
controlling abortions by the average sow inventory of the
week, pre-weaning mortality by the total number of pigs
born on the week, and total pigs weaned by the number of
sows weaned on the week. For neonatal losses, we used a
log-normal distribution, because it was the difference be-
tween two means. Exponential distribution with a log-link
function, was used for the wean-to-first-service interval,
since it was a time to event response. Moreover, herd was
used as random effect, and weeks after MLV vaccination
was used as a categorical fixed effect for all the models.
A level of significance of P < 0.05 was used to compare
the productivity of each week after the MLV interven-
tion (n = 6) to the baseline, with a one-sided p-value de-
tecting only if the change represented a negative impact
on performance. SAS 9.4 (SAS Institute, Inc., Cary,
NC) was used to conduct the Bonferroni adjustment
for multiple comparisons on the parameters that we
found to be significant, by including the ‘adjust = BON’
Fig. 1 Study design
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in the LSMEANS statement from the PROC GLIMMIX
model.
Results
There were 65 eligible herd-vaccinations, and 4 non-eligible
herd-vaccinations. The reason for non-eligibility were:
PRRSV outbreaks causing herd instability (n = 4). The me-
dian number of vaccinations per herd was 8, with mini-
mum of 5 and maximum of 11. The median period
between vaccinations was 13 weeks, with the minimum
value of 4 and maximum of 41. There were 780 production
record weeks evaluated.
On the SPC analysis, which described the herd-level
production losses following each of the 65 MLV vaccina-
tions, there were signals in abortions following 4
herd-vaccinations, a significant increase in neonatal
losses after 7 herd-vaccinations, significant increase in
pre-weaning mortality after 2 herd-vaccinations, and
increase in wean-to-first-service interval after 2
herd-vaccinations. There was no significant change on
total pigs weaned after MLV interventions (Table 1).
There was no significant negative effect of PRRS MLV
vaccination on the aggregated data of all herd vaccinations
for abortion rate (Table 2), neonatal losses (Table 3), pigs
weaned per sow (Table 4), or wean to first service interval
(Table 5) in any of the 6 weeks post vaccination compared
to the baseline period. However, there was an increase of
0.26% of pre-weaning mortality on the week 2 after vac-
cination compared to the baseline (Table 6).
Discussion
This study investigated the immediate effect of PRRS MLV
vaccination on selected key production performance indica-
tors. The ‘immediate’ effect was defined as a significant
change on production parameters within 6 weeks after vac-
cination, as compared to 6 weeks prior to vaccination. As
described in the materials and methods, the period of 6
weeks was chosen to represent the expected duration of the
viremic phase following infection of individual sows that
were pre-exposed to PRRSV. It was assumed that if PRRS
MLV vaccination had a significant impact on the productiv-
ity parameters under field conditions, the change would
have happened within the viremic phase of infection.
Under the conditions of this study, vaccinating for PRRS
using MLV had no significant impact on abortion rate, neo-
natal losses, pigs weaned per sow, and wean to first service
interval. The only significant production impact was an in-
crease in pre-weaning morality of 0.26% on the week 2 post
vaccination. This association of mass vaccination and in-
creased mortality after two weeks is possibly related to the
vaccine virus shedding and replication in the pigs. The rea-
son for having significant differences on mortality and no
impact on pigs weaned, is because the effect size of the dif-
ference was low. The impact of PRRS MLV vaccination on
overall herd productivity was not significant on a system
level, but there were some small transient changes in prod-
uctivity on individual farms. As previously mentioned, this
data provides information to best feed the existing eco-
nomic models to assist swine veterinarians and swine pro-
ducers to take informed decisions regarding the use of
PRRS MLV vaccine as a preventive strategy.
The implementation of preventive vaccination of the
breeding stock for PRRSv, with intent to minimize losses
following wild-type virus introduction has been described
[17, 18]. To the best of our knowledge, this is the first epi-
demiological study with multiple herd-vaccinations to
Table 1 Statistical process control (SPC) analysis of the data on
the individual farm level
Production parameter Frequency
of signalsa
Duration
of signals
Magnitude
of signals
Abortion rate 4/65 (6.1%) 1 to 7 weeks 0.11 to 0.16%
Neonatal losses 5/65 (7.7%) 1 to 5 weeks 0.34 to 1.85
Pre-weaning mortality 2/65 (3.1%) 1 to 5 weeks 3.99 to 5.21%
Total pigs weaned 0/65 (0.0%) N/A N/A
Wean-to-first-
service interval
2/65 (3.1%) 3 to 5 weeks 1.03 to 1.44 days
a = A decrease in productivity following each MLV intervention, with
performance parameters crossing the EWMA control limits, was defined as
a signal
Table 2 Means of abortion rate over time, following 65 herd
vaccinations, compared to baseline
Weeks post PRRSv
MLV vaccination
Abortion
rate means
Standard Error
of the mean
P-value*
Baseline 0.069% 0.000116 –
1 0.073% 0.000129 0.1658
2 0.070% 0.000124 0.4082
3 0.076% 0.000133 0.0775
4 0.068% 0.000119 0.6336
5 0.070% 0.000124 0.4148
6 0.068% 0.000120 0.6193
* = mixed regression model of each group compared to baseline
Table 3 Means of neonatal losses over time, following 65 herd
vaccinations, compared to baseline
Weeks post PRRSv
MLV vaccination
Neonatal
losses means
Standard Error
of the mean
P-value*
Baseline 0.979 0.05385 –
1 0.979 0.05933 0.4978
2 0.978 0.05933 0.5211
3 0.990 0.05933 0.3569
4 0.997 0.05933 0.2779
5 0.958 0.05952 0.7609
6 0.999 0.05952 0.2567
* = mixed regression model of each group compared to baseline
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document the effects of PRRS MLV vaccination on prod-
uctivity parameters under field conditions.
Previous research documented that the impact of mass
vaccination on overall breeding herd performance was 1
piglet per sow per year [12]. Results from this study sug-
gests that the impact of mass vaccination on PRRS-stable
breeding herds with type 2 PRRS MLV products is mini-
mum and much lower than 1 piglet per sow per year. These
results are supported by another research that reported no
significantly clinical signs on pigs vaccinated, compared to
the control non-vaccinated group [19].
Some negative effects of vaccinating pregnant sows for
PRRS with a MLV vaccine have been reported and contrast
the results of this study [13]. One study reported that the
vaccination should be avoided on pregnant sows and imple-
mented only on non-pregnant females, due to decreasing
of the number of pigs born alive and weaned [14]. On an-
other study, the same author reported that vaccinating sows
against PRRSV caused production losses by increasing the
number of stillbirths and mummified pigs [15].
Intrinsic factors from specific herds were in part ad-
justed for, by having the variable ‘Farm’ as random effect
in the regression models. Season has been reported as a
risk factor for PRRSv infection and related with changes in
production parameters of breeding sows, such as abor-
tions, neonatal losses, and pre-weaning mortality [20–23].
Thus, to take seasonality into account, this study had a dy-
namic baseline parameter for herd vaccination. More spe-
cifically, the effect of MLV vaccination on each production
parameter was compared to the average of 6 weeks prior
to vaccination, making the assessment of the effect of vac-
cinations robust to seasonal effects.
It is important to highlight that this study included
only PRRS-stable sow farms (according to the American
association of swine veterinarians criteria) [9], and thus
results may not be applicable to PRRS-naïve, and/or
positive-unstable PRRS sow farms. Moreover, the ana-
lysis was done for PRRSV type 2, and more studies
should be conducted to extrapolate the results to PRRSV
type 1. It was a limitation of the study the fact that it
was retrospective, which makes it naturally subjected to
recall and information bias.
Conclusions
Although some farms had transient changes in product-
ivity, at the aggregated data analysis level there was no
significant change in abortion rate, neonatal losses, num-
ber of pigs weaned per sow, and wean to first service
interval on PRRS-stable herds implementing PRRS MLV
routinely vaccinations. For pre-weaning mortality, there
was an increase of 0.26% on the week 2 after vaccin-
ation, compared to the baseline. According to the results
of this study, adopting quarterly mass vaccinations may
be a useful strategy to regularly immunize swine breed-
ing herds to PRRSv.
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